ArticleJournal of ovarian research2026
HOMA-IR partially mediates the association between percent appendicular skeletal muscle mass and IVF/ICSI outcomes.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSkeletal muscle mass contributes to metabolic health, particularly in relation to insulin sensitivity, and both skeletal muscle mass and metabolic health may influence outcomes after assisted reproductive technology (ART). However, whether insulin sensitivity partially explains the association between skeletal muscle mass and ART outcomes remains unclear. This study aimed to investigate the association between the percentage of appendicular skeletal muscle mass (PASM) and outcomes from in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) and to explore whether insulin resistance, assessed by HOMA-IR, partially mediates this association.
methodsThis retrospective study included 990 patients who underwent IVF/ICSI at Nanjing Medical University from April 2022 to April 2023. PASM was measured by bioelectrical impedance analysis (BIA) and analysed both as quartiles and as a continuous variable. Insulin sensitivity was assessed using the homeostatic model assessment of insulin resistance (HOMA‑IR). We employed Spearman's correlation analysis, multivariate regression, restricted cubic spline (RCS) models, and mediation analysis with adjustment for relevant confounders.
resultsUnadjusted comparisons showed only non-significant increasing trends across PASM quartiles, whereas adjusted regression analyses indicated more favourable laboratory outcomes in higher PASM quartiles. Each 1-unit increase in PASM was associated with the number of oocytes retrieved (Beta = 0.29), available embryos (Beta = 0.25) and blastocysts (Beta = 0.21), as well as higher available embryo rate (Beta = 1.49) and blastocyst formation rate (Beta = 1.52). PASM was positively linked to cumulative clinical pregnancy rate (CCPR) (OR = 1.30). Higher PASM was inversely associated with HOMA‑IR and insulin resistance (IR) prevalence; elevated HOMA‑IR was independently associated with poorer embryology laboratory indicators (P < 0.05). Mediation analysis suggested that HOMA-IR modestly mediated 5.5%, 5.9%, and 7.3% of the associations between PASM and the number of oocytes retrieved, available embryos and blastocysts, respectively.
conclusionsHigher PASM was associated with more favourable embryology laboratory indicators and higher pregnancy success after IVF/ICSI, with HOMA-IR showing partial and modest mediation. Interventions targeting skeletal muscle mass may represent a potential strategy for optimizing assisted reproduction outcomes, pending confirmation in prospective studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.